Cancer Institute A national cancer institute
designated cancer center

Scientific Review Committee (SRC)

The SRC is charged with providing peer review of local, national, and international research studies involving cancer patients treated at Lucile Packard Children's Hospital and Stanford Hospital and Clinics; and study participants involved in cancer-related research at Stanford University. Scientific review also applies to interventional studies based at the Cancer Prevention Institute of California (CPIC). SRC review is a requirement of the National Cancer Institute as part of our cancer center designation. Scientific review is required for all clinical interventional studies that involve cancer, cancer prevention, or survivorship. Scientific review is also required for non-interventional studies involving cancer, cancer prevention, or survivorship unless the non-interventional study has undergone peer review by an organization that the NCI considers acceptable; this list of organizations can be found here; these studies do still require OnCore entry. Prospective studies of tissue and/or body fluids with a scientific hypothesis that do not undergo review by the Stanford Cancer Institute’s Tissue Bank in lieu of SRC review, and have not undergone peer review to obtain funding, require review by the SRC. Studies that require a cancer diagnosis in the eligibility criteria require SRC review even if the focus of the study is not cancer. For studies that may enroll cancer patients as well as non-cancer patients, scientific review is required when the focus of the study is cancer. The primary focus of scientific review is on the scientific merit, feasibility, and utilization of Cancer Center resources.

Contact the SRC

SRC Submission Process

How to Submit an Initial SRC Application:

SRC Pre-Review of Investigator Initiated Studies:

All Investigator-initiated protocols submitted to the SRC will be pre-reviewed prior to the scientific review by the SRC; the purpose of the pre-review is to ensure that protocols contain all the required elements and they are organized in a consistent manner in the appropriate format.  The Checklist can be found via the URL below and is intended to be helpful in the protocol writing process.  Protocols that lack the necessary information will not be assigned SRC reviewers until the protocol has been revised.  Please allow sufficient time for this pre-review and revision (if necessary) process.  We will make every effort to be prompt in sending PIs the comments from the pre-review and hope that this process will eventually expedite the protocol development process.  The pre-review will allow the SRC reviewers to focus on the scientific merit of research protocols and to ensure they conform to the research objectives and priorities of the Stanford Cancer Center.  For questions on the SRC pre-review process, contact Jennifer Dylewski (dylewski@stanford.edu, (650)-724-4926). 

The protocol templates for Interventional and Non-interventional studies are in the CCTO website (http://cancer.stanford.edu/trials/admin/regulatory_resources/istudies.html).

How to Submit a Renewal to the SRC:

How to Submit a Modfication to the SRC:

The CCTO Regulatory Team is available to assist with the IRB and SRC application process.


SRC 2014 MEETING DATES
Mon
Jan 13
Noon FC180
Fri
Jan 24
Noon FC180
Mon
Feb 10
Noon FC180
Fri
Feb 21
Noon FC180
Mon
Mar 10
Noon FC180
Fri
Mar 21
Noon FC180
Mon
Apr 14
Noon FC180
Fri
Apr 25
Noon FC180
Mon
May 12
Noon FC180
Fri
May 23
Noon FC180
Mon
Jun 9
Noon FC180
Fri
Jun 20
Noon FC180
Mon
Jul 14
Noon FC180
Fri
Jul 25
Noon FC180
Mon
Aug 11
Noon FC180
Fri
Aug 22
Noon FC180
Mon
Sep 8
Noon FC180
Fri
Sep 19
Noon FC180
Mon
Oct 13
Noon FC180
Fri
Oct 24
Noon FC180
Mon
Nov 3
Noon FC180
Fri
Nov 14
Noon FC180
Mon
Dec 8
Noon FC180
 
 
 

SRC Resources

Stanford Medicine Resources:

Footer Links: